Variant report
Variant | nsv582307 |
---|---|
Chromosome Location | chr2:79076986-79084215 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142236679 | chr2:79082829-79082830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs188227007 | chr2:79082839-79082840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560671223 | chr2:79082854-79082855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192970770 | chr2:79082951-79082952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542423520 | chr2:79083040-79083041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550353484 | chr2:79083058-79083059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185194394 | chr2:79083084-79083085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532832882 | chr2:79083121-79083122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146403658 | chr2:79083181-79083182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112227210 | chr2:79083208-79083209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557400977 | chr2:79083277-79083278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566058903 | chr2:79083282-79083283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535042067 | chr2:79083286-79083287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1521965 | chr2:79083305-79083306 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs568547754 | chr2:79083422-79083423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139484826 | chr2:79083426-79083427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556318991 | chr2:79083452-79083453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576195934 | chr2:79083458-79083459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536491245 | chr2:79083464-79083465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540141227 | chr2:79083471-79083472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533331674 | chr2:79083472-79083473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369642874 | chr2:79083480-79083481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs6707481 | chr2:79083525-79083526 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs369246826 | chr2:79083616-79083617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558451834 | chr2:79083639-79083640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6707613 | chr2:79083666-79083667 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs540641354 | chr2:79083725-79083726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188956850 | chr2:79083753-79083754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574473076 | chr2:79083756-79083757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558396113 | chr2:79084213-79084214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs17015740 | chr2:79084215-79084216 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:79082800-79083800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:79084200-79085000 | Enhancers | Monocytes-CD14+_RO01746 | blood |